Bionano Genomics (BNGO) Invested Capital (2017 - 2025)

Bionano Genomics (BNGO) has 8 years of Invested Capital data on file, last reported at $3.7 million in Q3 2025.

• For the quarter ending Q3 2025, Invested Capital fell 1.78% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (down 50.67% YoY), and the FY2024 full-year result was $3.8 million, down 1.5% from the prior year.
• Invested Capital retreated to $3.7 million in Q3 2025, from $3.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.9 million in Q4 2021 to a low of $3.7 million in Q3 2025.
• A 5-year average of $3.9 million and a median of $3.9 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital fell 0.94% in 2022 and declined 1.78% in 2025, its largest moves.
• Tracing BNGO's Invested Capital over 5 years: stood at $3.9 million in 2021, then fell by 0.94% to $3.9 million in 2022, then declined by 1.2% to $3.9 million in 2023, then decreased by 1.5% to $3.8 million in 2024, then fell by 1.4% to $3.7 million in 2025.
• Business Quant data shows BNGO's Invested Capital at $3.7 million in Q3 2025, $3.8 million in Q2 2025, and $3.8 million in Q1 2025.